Literature DB >> 35776149

Comment on "Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer": Waxing-Waning Serum Calcium following Denosumab use in a patient with Polyostotic Paget's Disease of Bone.

Rimesh Pal1, Sanjay Kumar Bhadada2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35776149     DOI: 10.1007/s00198-022-06443-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   5.071


× No keyword cloud information.
  3 in total

1.  Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.

Authors:  Heather E Whitson; Bruce Lobaugh; Kenneth W Lyles
Journal:  Bone       Date:  2006-06-12       Impact factor: 4.398

2.  Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer.

Authors:  R Wang; D A Renouf
Journal:  Osteoporos Int       Date:  2022-03-14       Impact factor: 5.071

3.  Recurrent hypercalcaemia in a young man with mono-ostotic Paget's disease.

Authors:  P Bannister; M Roberts; P Sheridan
Journal:  Postgrad Med J       Date:  1986-06       Impact factor: 2.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.